Symposia at 2025 Midyear!

Don’t miss the ASHP Advantage Symposia at this year’s ASHP Midyear Clinical Meeting & Exhibition, where leading experts will provide engaging, in-person and virtual educational opportunities for attendees. Seating is limited and provided on a first-come, first-served basis.

If you are not attending the Midyear Clinical Meeting & Exhibition in person, register for the live webinars below.

Monday, Dec. 8
11:30 a.m. – 1 p.m. PT  |  2:30 – 4 p.m. ET

graphic representing the heart and kidneysAnd the Beat Goes On: Improving Heart Failure and Chronic Kidney Disease Outcomes with SGLT2 Inhibitors

This 1.5-hour educational activity will utilize patient cases to apply current guideline recommendations for early identification, screening, and treatment of patients with SGLT2 inhibitors in chronic kidney disease and heart failure.


illustration of the human body, brain and sensorsChronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Changing Therapeutic Landscape and the Role of the Pharmacist

This 1.5-hour educational activity discusses the pathophysiology of CIDP as well as the incidence, prevalence, clinical course, and burden of disease. A review of the current guideline-recommended therapies will be discussed, including any treatment limitations.




More details will be posted soon for:
  • Checkpoint Well Taken: Identification and Management of Immune Related Adverse Events for Healthcare Practitioners
  • Pump Up Your Knowledge: IV Smart Pumps and the Vital Role of the Pharmacist

Tuesday, Dec. 9
11:30 a.m. – 1 p.m. PT  |  2:30 – 4 p.m. ET

graphic of a human body with lungs and heartNavigating the Complex Landscape of Pulmonary Arterial Hypertension: A Roadmap for Pharmacists

This 1.5-hour educational activity reviews the latest guidelines and recommended treatment options for Pulmonary Arterial Hypertension, including drug selection, combination therapies, safety and when and how to adjust and escalate treatment.


Ready-to-Administer IV Push ProductsHurry, Time is Wasting: The Pharmacy Workforce and the Cost-Effectiveness and Safety of Ready to Administer Products

This 1.5-hour educational activity reviews the evidence for the safety and cost-effectiveness of ready-to-administer (RTA) prefilled syringes compared to the traditional vial-and-syringe method, presents the latest study on pharmacy-related costs associated with IV push products, and discusses real-world aspects of transitioning from traditional to RTA products.




More details will be posted soon for:
  • The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks
  • Tagged for Success: Impactful Applications and Future Opportunities of RFID Technology

Wednesday, Dec. 10
11:30 a.m. – 1 p.m. PT  |  2:30 – 4 p.m. ET

graphic of person in front of IV bagThe Whole Package: The Pharmacist’s Critical Role in Parenteral Nutrition and the Use of Multi-Chamber Bag Parenteral Nutrition

This 1.5-hour educational activity discusses appropriate patient selection for multi-chamber bag parenteral nutrition (MCB-PN) and how to safely prepare and dispense MCB-PN.




More details will be posted soon for:
  • Between a Rock and a Hard Plaque: The Relationship Between LDL-C and ASCVD Risk and Improving Patient Outcomes with PCSK9 Inhibitors
  • Finding Pneumo: Demystifying Pneumococcal Vaccine Evidence Recommendations

ADVERTISEMENT